Lupin Ltd Split

Lupin inks pact with China-based Gan & Lee for bofanglutide

 Copy Link

As per the terms of agreement, Lupin will hold exclusive rights for commercialisation and distribution of bofanglutide in India.

Top Stocks for Today - 30th December 2025

 Copy Link

Here are some of the stocks that may see significant price movement today: Lupin, Bandhan Bank, Jubilant Foodworks, etc.

Top Stocks for Today - 19th December 2025

 Copy Link

Here are some of the stocks that may see significant price movement today: HCL Tech, Bharti Airtel, Amber Enterprises, etc.

Lupin posts ~73% y-o-y growth in Q2 net profit

 Copy Link

The business said that its revenue from operations registered a growth of 24.20% y-o-y at ₹7,047.50 Crore.

Lupin Shares Decline After USFDA Issues Six Observations for Nagpur Plant

 Copy Link

The inspection was held between September 8 and 16. Lupin did not disclose the details of the observations but said it would respond within the required timeline.

Lupin Launches Glucagon Kit in US, Eyes $122 Mn Market

 Copy Link

The launch aligns with Lupin’s strategic push into injectables, biosimilars, and inhalation therapies, supported by robust R&D and manufacturing capabilities

Top Stocks for Today - 6th August 2025

 Copy Link

Here are some of the stocks that may see significant price movement today: Bharti Airtel, Torrent Power, Lupin Limited, etc.

Lupin gets USFDA approval for post-eye surgery drug

 Copy Link

This is eligible for 180 days of generic drug exclusivity. The company will manufacture the product at its facility situated in India.

Top Stocks for Today - 2nd July 2025

 Copy Link

Here are some of the stocks that may see significant price movement today: Godrej Properties, SBI Cards, Hyudai India, etc.

Lupin Expands US Presence with Launch of Prucalopride Tablets

 Copy Link

The tablets will be made at the company’s Goa facility, a site that has previously cleared global regulatory inspections and supports Lupin’s key exports.